Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.

Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA.

Am Heart J. 2004 Jul;148(1):157-64.

PMID:
15215806
2.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
4.

Oral anticoagulants in patients with coronary artery disease.

Anand SS, Yusuf S.

J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):62S-69S. Review.

PMID:
12644343
5.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
6.

The role of warfarin and aspirin in secondary prevention of stroke.

Elkind MS.

Curr Cardiol Rep. 2004 Mar;6(2):135-42. Review.

PMID:
14759359
7.

Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B.

Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21. Review.

8.

Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.

Thatai D, Ahooja V, Pullicino PM.

Am J Cardiovasc Drugs. 2006;6(1):41-9. Review.

PMID:
16489847
9.

Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.

Redman AR, Allen LC.

Curr Atheroscler Rep. 2002 Jul;4(4):319-25. Review.

PMID:
12052284
10.

What do we know about anticoagulation in patients with heart failure?

Ahnert AM, Freudenberger RS.

Curr Opin Cardiol. 2008 May;23(3):228-32. doi: 10.1097/HCO.0b013e3282fcd64d. Review.

PMID:
18382211
11.

Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.

Lip GY, Gibbs CR.

QJM. 2002 Jul;95(7):451-9. Review.

PMID:
12096150
12.

Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review.

Sirajuddin RA, Miller AB, Geraci SA.

J Card Fail. 2002 Feb;8(1):48-53. Review.

PMID:
11862583
13.

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.

Andreotti F, Testa L, Biondi-Zoccai GG, Crea F.

Eur Heart J. 2006 Mar;27(5):519-26. Epub 2005 Sep 5. Review.

PMID:
16143706
14.
15.
16.

Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.

Kumar G, Goyal MK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1279-87. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.015. Epub 2012 Nov 20. Review.

PMID:
23182364
17.

Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

Donadini MP, Douketis JD.

J Thromb Thrombolysis. 2010 Feb;29(2):208-13. doi: 10.1007/s11239-009-0413-4. Review.

PMID:
19915994
18.

Anticoagulation and heart failure.

Graham SP.

Curr Cardiol Rep. 2001 Jan;3(1):72-7. Review.

PMID:
11139802
19.
20.

To anticoagulate or not to anticoagulate patients with cardiomyopathy.

Graham SP.

Cardiol Clin. 2001 Nov;19(4):605-15. Review.

PMID:
11715181

Supplemental Content

Support Center